Novo Nordisk A/S vs Star Bulk Carriers Corp — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Star Bulk Carriers Corp trades at $26.59 (market cap $2.91B). The key difference: Novo Nordisk A/S is far larger — about 75.8× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays the higher dividend (3.95%). Which is the better fit depends on your goals.
| NVO | SBLK | |
|---|---|---|
Market Cap | $220.53B | $2.91B |
Sector | Health | Industrials |
52-Week High | $71.70 | $28.21 |
52-Week Low | $35.29 | $16.79 |
Enterprise Value | $239.49B | $3.61B |
Dividend Yield | 3.63% | 3.95% |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →